Who
Kevin Michael Coveney
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Enveric Biosciences.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Mar 2023
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 23 Dec 2025filed 30 Dec 2025 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —40,198 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —74,150 at $0.00 | filing |
| 9 Oct 2024filed 11 Oct 2024 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 13 Mar 2023filed 14 Mar 2023 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —26,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.